Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Corrigendum to 'Long-term outcomes with adjuvant CDK4/6 inhibitors: who benefits most?': [Annals of Oncology. Volume 37, Issue 2, February 2026, Pages 133-135].
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 08, 2026
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
Learning Patient Similarity from Genomics for Precision Oncology.
Journal: medRxiv : the preprint server for health sciences
Published: December 25, 2025
The Pan-Tumor Landscape of Gene Amplifications and Copy Number Amplification Ratio for Established and Emerging Clinical Targets.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 22, 2025
Long-term outcomes with adjuvant CDK4/6 inhibitors: who benefits most?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 06, 2025
Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.
Journal: JCO precision oncology
Published: September 04, 2025
Implementing a context-augmented large language model to guide precision cancer medicine.
Journal: medRxiv : the preprint server for health sciences
Published: August 08, 2025
A context-augmented large language model for accurate precision oncology medicine recommendations.
Journal: Cancer cell
Published: July 15, 2025
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer.
Journal: Journal of the National Cancer Institute
Published: April 04, 2025
Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the EMERALD Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 22, 2025
Last Updated: 09/26/2026